About: An emerging allergen: Cannabis sativa allergy in a climate of recent legalization

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: An emerging allergen: Cannabis sativa allergy in a climate of recent legalization Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	An emerging allergen: Cannabis sativa allergy in a climate of recent legalization
Creator	Cleto, Erica Jackson, Bradley Jeimy, Samira
source	PMC
abstract	Considering its recent legalization in Canada, the health implications of Cannabis sativa exposure, including allergy, are coming to the forefront of medical study and interest. C. sativa allergy is an issue that affects recreational users of the substance, processors, agricultural workers, and contacts of Cannabis aeroallergens and secondhand product. Allergies to C. sativa are heterogenous and span the spectrum of hypersensitivity, from dermatitis to rhinoconjunctivitis to life-threatening anaphylaxis. Due to its recent legalization, sensitized individuals will have increasing exposure from direct contact to agricultural pollens. Diagnosis and treatment of Cannabis allergy are developing fields that are already showing promise in the identification of culprit antigens and the potential for immunotherapy; however, much responsibility still falls on clinical diagnosis and symptom management. Hopefully, given the current explosion of interest in and use of Cannabis, C. sativa allergy will continue to garner awareness and therapeutic strategies.
has issue date	2020-06-26(xsd:dateTime)
bibo:doi	10.1186/s13223-020-00447-9
has license	cc-by
sha1sum (hex)	14ca05b836d524440687fee8fe48571333ab1cfb
schema:url	https://doi.org/10.1186/s13223-020-00447-9
resource representing a document's title	An emerging allergen: Cannabis sativa allergy in a climate of recent legalization
has PubMed Central identifier	PMC7371810
schema:publication	Allergy Asthma Clin Immunol
resource representing a document's body	covid:14ca05b836d524440687fee8fe48571333ab1cfb#body_text
is schema:about of	named entity 'management' named entity 'sensitized' named entity 'individuals' named entity 'awareness' named entity 'study' named entity 'strategies' named entity 'PRODUCT' named entity 'AGRICULTURAL' named entity 'RHINOCONJUNCTIVITIS' named entity 'ALLERGIES' named entity 'CURRENT' named entity 'INCREASING' named entity 'ALLERGY' named entity 'ALLERGEN' named entity 'legalization' named entity 'developing' named entity 'explosion' named entity 'implications' named entity 'processors' named entity 'Canada' named entity 'current' named entity 'agricultural' named entity 'Cannabis' named entity 'aeroallergens' named entity 'Canada' named entity 'Cannabis' named entity 'Cannabis sativa' named entity 'anaphylaxis' named entity 'Cannabis' named entity 'recreational users' named entity 'clinical diagnosis' named entity 'life-threatening' named entity 'Cannabis' named entity 'allergen' named entity 'allergy' named entity 'pollen' named entity 'Cannabis' named entity 'allergy' named entity 'C. sativa' named entity 'Cannabis' named entity 'allergies' named entity 'gold standard' named entity 'basophil' named entity 'immunoblot' named entity 'Cannabis farm' named entity 'aeroallergen' named entity 'allergy' named entity 'aeroallergen' named entity 'Skin testing' named entity 'allergens' named entity 'lipid' named entity 'terpenoid' named entity 'Cannabis' named entity 'Cannabis sativa' named entity 'Cannabis' named entity 'Cannabis sativa' named entity 'non-specific' named entity 'allergist' named entity 'protein' named entity 'RuBisCO' named entity 'C. ruderalis' named entity 'Cannabis' named entity 'hops' named entity 'protein' named entity 'immunosuppressed' named entity 'allergy' named entity 'aeroallergen' named entity 'Anaphylaxis' named entity 'protein' named entity 'Cannabis' named entity 'IgE' named entity 'antihistamines' named entity 'atopy' named entity 'Basophil activation' named entity 'fruit' named entity 'clinical testing' named entity 'allergens' named entity 'hypersensitivity pneumonitis' named entity 'biochemistry' named entity 'Thaumatin' named entity 'Canadian'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software